TRPM8 and prostate cancer: Since sM8s are negative regulatory sub-units of the cold and menthol receptor [15], and because TRPM8 channel has been considered as a target of interest in cancer therapy [16], we assessed whether sM8s knockdown (KD) could affect prostate cancer cell growth.